Nammude Arogyam May 2018 | Page 45

Hcp ÌUn-bn \n¶v At\
Iw Nn{X-§Ä e`n-¡p¶p
F¶p-ÅXv t\«w Xs¶-bm
-Wv. kvX\-§-fnse apg-IÄ
km[m-cW tImi-I-e-IÄ
aqew ad-ªp -t]m-Ip¶
AhØ ]qÀ®ambpw
Hgn-hm-¡m³ km[n-¡pw.
At\Iw tOZ Nn{X
-§Äs¡m¸w (Cross Section)
{Xnam\ Nn{X-§fpw e`n-¡p
-¶Xv tcmK-\nÀWbw
]ng-h-ä-Xm-¡p-¶p.
amtam-{K^n Ft¸mÄ
amtam-{K-^n-bpsS klm
-b-¯m kvX\mÀ_pZw
Bcw-`-Z-i-bn Xs¶
Isï-¯m³ km[n-¡pw.
aq¶p Xe-¯n-emWv amtam
-{K^n D]-tbm-Kn-¡-s¸-Sp-¶
-Xv. tcmK-\nÀWbw
(Diagnostic), XpSÀ NnInÕ
(Follow up), kv{Io\n§v
(Screening).
XpSÀ NnInÕm amtam-{K^n
(i) kvX\mÀ_pZw h¶v apg
\o¡w sNbvXn-«p-sï
-¦nÂ
(ii) kvX\mÀ_pZw h¶v
kvX\w \o¡w sNbvXn
-«p-sï-¦nÂ
kv{Io\n§v amtam-{K^n
tcmK-e-£-W-§fpw
apg-Ifpw hcp-¶-Xn\p
apt¼ Xs¶ kvX\mÀ
_pZw Isï-¯p-I-bmWv
kv{Io\n-§nsâ e£yw.
CXp-aqew ]qÀW-amb
tcmK-\n-hm-c-Ww, km²y-am
-Wv. AtXm-sSm¸w Xs¶
tcmKm-h-Ø-bpsS Zqjy-^
-e-§Ä (Morbidity), kvX
\mÀ_pZw aqe-ap-ïm-Ip¶
acWw F¶nh KWy-ambv
Ipd-bp-¶p. kv{Io\n§v
amtam-{K-^n-bn Hmtcm
kvX\-¯n-sâbpw MLO
(DÅn \n¶pw ]pd
-t¯bv¡p t\m¡p¶ coXn)
tdUn-tbm-{Km^mWv FSp
-¡p-¶-Xv. CXv tdUn-tbm-f
-PnÌv ]cn-tim-[n-¨-Xn-\p-
ti-jw, kwi-bm-kv]-Z-amb
`mKw Isï-¯n-bmÂ,
XncnsI hnfn-¨v, ¢n\n-¡Â
]cn-tim-[-\, k¼qÀ®
amtam-{K^n F¶n-hbv¡v
hnt[ bam¡pw. Cu
]cn-tim-[-\-I-fpsS ASn
-Øm-\-¯n AÄ{Sm
-kuïv (USG), Fw.-BÀ.sF
(MRI), _tbm]vkn (Biopsy)
F¶nh Bh-iy-ambv
ht¶-¡mw. Xmsg-¸-d-bp¶
kml-N-cy-¯n-emWv
kv{Io\n§v sNt¿-ï-Xv.
(i) 40 hb-Ên\p apI-fn-epÅ
kv{XoIÄ hÀj-¯n-sem
-cn-¡Â kv{Io\n§v
sN¿p-¶Xv A`n-Im-ay-
am-Wv.
tcmK-\nÀWb amtam-{K^n
Xmsg-¸-d-bp¶ tcmK-e
-£-W-§Ä DÅ-hÀ ¢n\n-
-¡Â ]cn-tim-[-\bv¡p
tijw amtam-{K^n sNt¿
-ï-Xp-ïv.
(i) kvX\-¯n-ep-ïm-Ip¶
apg-IÄ
(ii) ape-sR-«n \n¶v
{khw (Discharge) ape
-sR«v DÅn-te¡p hen
-bp-I.
(iii) I£-¯n-ep-ïm-Ip¶
ho¡w.
(iv) akvXn-jvIw, izmk-tIm
-iw, IcÄ F¶n-h-bnÂ
AÀ_pZw ]SÀ¶-Xmbn
Iïm (Metastases).
\½p-sS B-tcm-Kyw | sabv 2018 45